Faecal microbiota signature for pancreatic cancer

Patent number:

WO2023/052486

Comunidad de Madrid.svg
No items found.

The CNIO has developed a method for early detection of pancreatic cancer. The inventors have found a method for early diagnosing pancreatic cancer based on a faecal microbiota signature with high specificity for pancreatic cancer.

Countries:
Spain
Regions:
Community of Madrid
Centers:
CNIO, FUNDACION CNIO
Other entities:
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The method of the invention is a sensitive, specific and non-invasive method for an early detection of pancreatic cancer, in particular Pancreatic Ductal Adenocarcinoma (PDAC) that could therefore improve survival outcomes. The present invention refers to a method for diagnosing pancreatic cancer in a subject comprising determining the abundance of several Microbiome species in a faecal sample from said subject, as well as to a kit and its use for the diagnosis of pancreatic cancer.

Comments

Other related patents

Health

Healthier cigarettes for Heated Tobacco Products (HTPs)

Countries
Spain
Know more
Health
New & Sustainable Materials
Construction

New Basanite Nanoparticle Production Method

Countries
Spain
Know more
Energy
Health
Circular Economy
Food & Agro

Method for culturing oleaginous yeasts

Countries
Spain
Know more
Get back to patents directory